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Caveolae are 25–100 nm flask-like membrane structures enriched in cholesterol and glycosphingolipids. Researchers have
proposed that Campylobacter jejuni require caveolae for cell invasion based on the finding that treatment of cells with the
cholesterol-depleting compounds filipin III or methyl-β-cyclodextrin (MβCD) block bacterial internalization in a dose-
dependent manner. The purpose of this study was to determine the role of caveolae and caveolin-1, a principal compo-
nent of caveolae, in C. jejuni internalization. Consistent with previous work, we found that the treatment of HeLa cells with
MβCD inhibited C. jejuni internalization. However, we also found that the treatment of HeLa cells with caveolin-1 siRNA,
which resulted in greater than a 90% knockdown in caveolin-1 protein levels, had no effect on C. jejuni internalization.
Based on this observation we performed a series of experiments that demonstrate that MβCD acts broadly, disrupting
host cell lipid rafts and C. jejuni-induced cell signaling. More specifically, we found that MβCD inhibits the cellular events
necessary for C. jejuni internalization, including membrane ruffling and Rac1 GTPase activation. We also demonstrate that
MβCD disrupted the association of the β1 integrin and EGF receptor, which are required for the maximal invasion of
epithelial cells. In agreement with these findings, C. jejuni were able to invade human Caco-2 cells, which are devoid of
caveolae, at a level equal to that of HeLa cells. Taken together, the results of our study demonstrate that C. jejuni intern-
alization occurs in a caveolae-independent manner.
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Campylobacter jejuni is responsible for a significant
proportion of human morbidity and mortality in both
developing and developed countries. Most cases of cam-
pylobacteriosis result from consumption of foods cross-
contaminated with undercooked chicken products.
Acute disease is dependent upon the ability of C. jejuni
to bind and invade the cells lining the human gastro-
intestinal tract. While significant progress has been
made in identifying and characterizing the bacterial
components that contribute to the development of dis-
ease in humans, how the bacterium manipulates the host
intestinal cells during infection is less well-defined. For
more than a decade researchers have proposed that C.
jejuni invasion of intestinal cells requires specialized struc-
tures called caveolae. We present evidence demonstrating
that C. jejuni internalization is not dependent on caveolae,
but requires the cellular components that comprise the* Correspondence: konkel@vetmed.wsu.edu
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reproduction in any medium, provided the orfocal complex. Our data provides new insight into the
mechanism that C. jejuni utilizes to invade intestinal cells.
Elucidation of the mechanism of C. jejuni cell invasion will
aid in the development of novel intervention methods to
reduce human disease.Background
Campylobacter jejuni is one of the leading bacterial
causes of human gastrointestinal disease worldwide.
Clinical and experimental research demonstrates that
acute disease involves C. jejuni invasion of the cells lin-
ing the gastrointestinal tract [1-5]. While progress has
been made in identifying C. jejuni virulence determi-
nants, the mechanism of cell invasion and the host cell
components involved in C. jejuni uptake are less well-
defined.
Lipid rafts are distinct regions of the plasma membrane
that contain high concentrations of cholesterol and gly-
cosphingolipids [6]. Caveolae are a special type of lipid
raft. Caveolar membranes contain caveolins, which bind
cholesterol and form complexes with glycosphingolipidsLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proteins [7]. Three members of the caveolin gene family
have been identified (caveolin-1, caveolin-2, and caveolin-
3). Caveolin-1, a 21 to 24-kDa integral membrane protein,
is a principal component of caveolar membranes and a
major component of the vesicular transport system in the
trans-Golgi network [8,9]. Caveolin-2 tightly interacts with
caveolin-1. More specifically, the interaction with caveolin-
1 is necessary for transport of caveolin-2 to the plasma
membrane, where the two proteins form hetero-oligomeric
complexes within caveolae [10]. Caveolin-2 is a minor com-
ponent of the hetero-oligomeric complexes, and is readily
degraded in the absence of caveolin-1 [11]. Caveolin-2 has
been proposed to act as a co-factor for caveolae formation,
regulating the size and shape of the structures. Relevant to
this study, caveolin-2 is not necessary for caveolae forma-
tion, and caveolin-1 and caveolin-2 are not expressed in all
cells [10,12]. In contrast to caveolin-1 and caveolin-2, cave-
olin-3 is only expressed in striated muscle [13,14].
Evidence from a number of in vitro studies has suggested
that caveolae play a role in C. jejuni invasion. Wooldridge
et al. [15] demonstrated that treatment of Caco-2 cells with
the polyene antifungal agent filipin III, which binds to and
sequesters cholesterol in the membrane [8,16], inhibited C.
jejuni internalization of human Caco-2 cells in a dose-
dependent manner [15]. A decade later Hu et al. [17] per-
formed similar experiments using human INT 407 epithe-
lial cells, and found that treatment of these cells with filipin
III resulted in a dose-dependent reduction in C. jejuni inva-
sion [17]. Similarly, Watson and Galan found that the treat-
ment of human T84 cells with the cholesterol-depleting
compound methyl-β-cyclodextrin (MβCD) blocked C.
jejuni internalization in a dose-dependent manner [45].
These investigators also reported that transfection of Cos-1
fibroblast-like cells with a dominant-negative (DN) mutant
of caveolin-1 (caveolin-1 Tyr-14 F), which prevents
caveolin-1 activation by preventing the phosphorylation of
tyrosine-14, significantly decreased C. jejuni internalization.
To further dissect the importance of caveolae in C. jejuni
internalization, the Cos-1 cells were transfected with a
dominant-negative form of dynamin II (dynII K44A) to
inhibit caveolae-dependent endocytosis. In contrast to the
cells expressing the DN form of caveolin-1, C. jejuni
internalization was not inhibited in cells expressing the DN
form of dynamin II. The investigators concluded that the
role of caveolin-1 in C. jejuni internalization might not be
related to its role in caveolae-mediated endocytosis, but
that caveolae or caveolin-1 may play a role in the host cell
signaling events necessary for bacterial uptake. As recent
as 2012, investigators proposed a model of C. jejuni
internalization involving caveolae structures [18].
We have previously proposed a model of C. jejuni-me-
diated invasion whereby this pathogen activates numer-
ous components that comprise the focal complex,resulting in cytoskeletal rearrangement and bacterial intern-
alization [19]. Focal complexes are dynamic cellular struc-
tures that form transient attachments, often at the tip of a
cellular protrusion. They connect extracellular matrix
(ECM) components, including fibronectin, to the actin
cytoskeleton and anchor the cell to the underlying surface.
Focal complexes are comprised of integrin receptors,
adaptor proteins (e.g., paxillin), signaling proteins (e.g., focal
adhesion kinase (FAK)), and actin. We have found that the
binding of C. jejuni to fibronectin induces the phosphoryl-
ation of paxillin, indicating host cell signal transduction
from the extracellular matrix through the α5β1 integrin re-
ceptors [20]. C. jejuni internalization is dependent upon the
activation of paxillin, Src, FAK, and Dock180 at the sites of
bacterial invasion [19]. Finally, C. jejuni is responsible for
the activation of the Rho GTPases Cdc42 and Rac1, which
induce the host cell membrane ruffling necessary for bac-
terial uptake [19,21]. Interestingly, inhibitors that prevent
the activation of the Epidermal Growth Factor (EGF) recep-
tor also inhibit C. jejuni internalization [19]. In summary,
C. jejuni can activate components of the focal complex,
which in turn interact with other host cell scaffold and sig-
naling proteins including the EGF receptor.
The purpose of this study was to determine the role of
caveolae and caveolin-1, the principal marker protein of
caveolae, in C. jejuni internalization. We demonstrate
that caveolin-1 is associated with the active form of the
EGF receptor in response to C. jejuni infection, but that
caveolin-1 is not required for C. jejuni internalization.
The results of our studies support the proposal that C.
jejuni internalization is dependent upon activation of
components of the focal complex.
Results
Part I. C. jejuni cell invasion, but not Cia protein delivery,
is inhibited by MβCD treatment
C. jejuni invasion is sensitive to treatment of cells with
MβCD
Researchers have concluded that the uptake of C. jejuni by
host cells is dependent upon caveolae based on the finding
that the treatment of epithelial cells with cholesterol-
sequestering and cholesterol-depleting compounds, includ-
ing filipin III and MβCD, inhibit C. jejuni invasion [15,17].
Consistent with previous reports, we found that treatment
of HeLa cells with MβCD reduced C. jejuni internalization
in a dose-dependent manner (Figure 1). Noteworthy is that
treatment of HeLa cells with MβCD had no effect on C.
jejuni binding to the epithelial cells (not shown) and im-
portantly, the level of C. jejuni invasion was restored to that
of untreated cells when the cells pre-treated with MβCD
were supplemented with cholesterol prior to the infection
(Additional file 1: Figure S1). Unsurprisingly, the cellular
localization of caveolin-1 in HeLa cells treated with MβCD
was different from untreated cells as judged by
Figure 1 Treatment of HeLa cells with the cholesterol-depleting
compound methyl-β-cyclo-dextrin (MβCD) reduces C. jejuni
internalization. HeLa cells were treated with 1.25, 2.5, 5.0, and
7.5 mM of MβCD for 30 min prior to inoculation with C. jejuni, as
outlined in the ‘Methods’ section. The control consisted of cells
infected with C. jejuni in the absence of the inhibitor in medium
containing vehicle (water). Bars indicate the mean of the number of
internalized bacteria. The asterisks indicate a significant reduction in
C. jejuni internalization compared to cells infected with C. jejuni in
the absence of the inhibitor in medium alone, as judged by
one-way ANOVA followed by post-hoc Dunnet’s analysis (P < 0.05).
Each error bar represents ± the standard deviation of the mean (SD).
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S2). To ensure that the effect of MβCD on C. jejuni intern-
alization was not unique to this chemical compound, simi-
lar experiments were performed with 2-hydroxypropyl-β-
cyclodextrin (HPβCD). Treatment of HeLa cells with
HPβCD, which also promotes extensive release of choles-
terol from cells, reduced C. jejuni internalization in a dose-
dependent manner (Additional file 3: Figure S3). A greater
reduction was observed in the number of C. jejuni internal-
ized in MβCD treated cells versus HPβCD treated cells,
which is consistent with the previous findings that indicate
that MβCD is more potent than HPβCD at extracting
cholesterol from biological membranes [22]. Treatment
of cells with filipin III or nystatin, which are cholesterol-
sequestering agents [8,16,23], led to a moderate increase in
C. jejuni internalization (Additional file 4: Figure S4). This
result is consistent with recent findings with Francisella
[24]. The fact that C. jejuni internalization is inhibited by
MβCD and HPβCD is consistent with the hypothesis that
efficient cell invasion requires the presence of cholesterol in
the plasma membrane.C. jejuni membrane ruffling is sensitive to treatment of cells
with MβCD
Assays were performed to determine if C. jejuni were
able to induce membrane ruffling in HeLa cells treatedwith MβCD, as previous studies have indicated that host
cell membrane ruffling is required for C. jejuni cell in-
vasion [19,21]. We chose to use MβCD rather than
HPβCD for this experiment and in many of the other of
the experiments performed in this study, as it was found
to be a more potent inhibitor of C. jejuni internalization.
We also treated the epithelial cells with nocodazole and
cytochalasin D, in part as controls, as these inhibitors
have been reported to reduce C. jejuni internalization.
Nocodazole binds β-tubulin, thereby preventing tubulin
polymerization [25], whereas cytochalasin D inhibits actin
polymerization and transient integrin-stimulated focal ad-
hesion kinase (FAK) activation [26]. The HeLa cells were
pre-treated for 30 min with MβCD, nocodazole, and cyto-
chalasin D to target host cell processes, inoculated with C.
jejuni, and then examined by SEM for membrane ruffling.
EGF treated cells served as the positive control, whereas
uninoculated HeLa cells were used as a negative control.
EGF treatment of epithelial cells was used as a positive
control because it can rescue a C. jejuni invasion-deficient
mutant, in part, because it stimulates membrane ruffling
[19]. We observed that 65.0% (n = 135 of 208) of the
cells infected with C. jejuni showed membrane ruffling
(Figure 2). In contrast, membrane ruffling was signifi-
cantly reduced (~38%, P < 0.05) in C. jejuni-infected
cells that were pre-treated with MβCD, nocodazole, and
cytochalasin D (Figure 2). Treatment of HeLa cells with
MβCD, nocodazole, and cytochalasin D did not result in
cell death as judged by trypan blue staining (not shown).
These findings demonstrate that drugs that target differ-
ent host cell structural components and processes can
prevent C. jejuni-induced host cell membrane ruffling.
These data further indicate that C. jejuni invasion of
host cells is dependent upon lipid rafts, as a significant
reduction in internalization was observed in epithelial
cells with MβCD.
Treatment of HeLa cells with MβCD prevents Rac1
activation but not Cia protein delivery
Maximal C. jejuni invasion of host cells requires the
Campylobacter invasion antigens (Cia). The Cia pro-
teins are synthesized and exported from the flagellar
Type III Secretion System (T3SS) in response to the
conditions that the bacterium encounters in vivo. We
have found that CiaC is delivered to host cells and is
necessary for the recruitment and activation of the
Rho GTPase Rac1 [19,27]. Here we used the adenyl-
ate cyclase domain (ACD) reporter assay to determine
if CiaC was delivered to the cytosol of HeLa cells
pre-treated with MβCD, nocodazole, cytochalasin D,
and TAE 226. The inhibitor TAE 226 specifically sup-
presses ECM-dependent phosphorylation of FAK at
Tyr-397 and Tyr-861 [28]. Infection with C. jejuni
synthesizing the CiaC-ACD fusion protein resulted in
Figure 2 C. jejuni-induced membrane ruffling is dependent on functional lipid rafts, microtubules, and microfilaments, as judged by
scanning electron microscopy (SEM) examination of cells. Negative and positive controls consisted of uninfected (Panel A) and EGF-treated
HeLa cells (Panel B). SEM images of HeLa cells infected with C. jejuni without an inhibitor (Panels C and G) and in the presence of methyl-β-
cyclodextrin (MβCD) (Panels D and H), cytochalasin D (Panels E and I), and nocodazole (Panels F and J). Indicated within the figure is the
percentage of cells with membrane ruffling of N number of total cells. Arrows indicate C. jejuni associated with host cells. The images shown in
Panels A-F were collected at the same magnification and the images shown in Panels G-J were collected at the same magnification.
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with each inhibitor compared to HeLa cells infected with
C. jejuni synthesizing the MetK-ACD fusion protein
(Figure 3A). MetK-ACD was used as a negative control in
this assay, as the metK gene encodes for S-adenosyl-
methionine synthetase that is localized in the bacterial
cytoplasm [29]. Based on these results, none of the drugs
that targeted the host cell processes altered the delivery of
the Cia proteins from the bacteria to the host cells.
Noteworthy is that C. jejuni internalization is depen-
dent upon the activation of the Rho GTPases Rac1
and Cdc42 [19,21]. Moreover, the activation of Rac1
has been reported to result in membrane ruffles
[30,31]. We used a Rac1 G-LISA™ to determine the
level of activated Rac1 in HeLa cells pre-treated with
MβCD, nocodazole, and cytochalasin D and infected
with C. jejuni. In contrast to untreated and cytochala-
sin D treated cells that were infected with C. jejuni, a
significant decrease was observed in the level of acti-
vated Rac1 in C. jejuni infected HeLa cells treated
with MβCD and nocodazole (Figure 3B). Collectively,
these data indicate that MβCD and nocodazole act toprevent or block the host signal transduction events
leading to the activation of Rac1.
Part II. C. jejuni in the process of cell invasion are
associated with FC components
C. jejuni is associated with components of the focal
complex
Based on previous work suggesting that C. jejuni intern-
alization is dependent upon the recruitment and activa-
tion of components of the focal complex, confocal
microscopy experiments were performed to determine if
C. jejuni are co-localized with components of the focal
complex [32]. Paxillin and vinculin are two key compo-
nents that comprise the focal complex [33]. The associ-
ation of C. jejuni with the host cell proteins paxillin and
vinculin was examined 45 min post-inoculation by con-
focal microscopy. Although only a small fraction of bac-
teria are in the process of internalization, examination
of the C. jejuni-infected HeLa cells readily revealed sites
of C. jejuni co-localized with paxillin and vinculin
(Additional file 5: Figure S5 A and B and Additional
file 6: Figure S6). More specifically, quantitative analysis
Figure 3 Disruption of lipid rafts and microtubules, but not microfilaments, inhibits the activation of the Rho GTPase Rac1 in C.
jejuni-infected HeLa cells. Assays were performed to assess the delivery of the C. jejuni CiaC protein to the cytosol of HeLa cells (Panel A) and to
determine the level of Rac1 activity in C. jejuni-infected HeLa cells (Panel B). HeLa cells were pre-treated methyl-β-cyclodextrin (MβCD) (5 mM),
nocodazole (20 mM), cytochalasin D (1 mM), and TAE 226 (5 μM) and infected with C. jejuni as outlined in ‘the ‘Methods’ section. Panels: A)
Delivery of the CiaC-ACD fusion protein from C. jejuni to the cytosol of HeLa cells was assayed using the adenylate cyclase domain (ACD)
reporter delivery assay. The concentration of cAMP within HeLa cells was assayed 30 min post-infection. The error bars represent mean ± standard
deviation (SD) from five independent experiments. The level of cAMP for cells infected with C. jejuni in the absence of an inhibitor was significantly
greater than for the negative control MetK-ACD, as judged by one-way ANOVA followed by post-hoc Tukey’s analysis. None of the treatments resulted
in a value significantly (P < 0.05) different from the control (HeLa cells infected with C. jejuni in the absence of a host cell inhibitor). B) Rac1 activation
in host cells infected with C. jejuni. Whole cell lysates were analyzed for activated Rac1 by G-LISA™. The mean ± SD of total active Rac1 is indicated in
Relative Optical Density. The data shown represent analysis of four samples. The asterisks indicate a significant difference (P < 0.01) in the level of Rac1
activation in cells infected with C. jejuni in the presence versus absence of a host cell inhibitor, as judged by one-way ANOVA followed by post-hoc
Tukey’s analysis.
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than 40% of the cell-associated bacteria were co-
localized with paxillin and vinculin. Experiments were
then performed to determine if MβCD treatment of
HeLa cells effected the co-localization of C. jejuni with
focal complex components. The treatment of HeLa cells
with MβCD appeared to increase the size of the focal
adhesion and resulted in a decrease in the number of
cell-associated bacteria that were co-localized with paxil-
lin and vinculin (Additional file 5: Figure S5 C and D).
Caveolin-1 is associated with the components of the
focal complex
Caveolin-1 can modulate the turnover of the focal adhe-
sion by binding to components of the focal complex, in-
cluding the epidermal growth factor (EGF) receptor
[34-36]. More specifically, the phosphorylated form of
caveolin-1 (caveolin-1 pTyr-14), which is excluded from
caveolae, serves as an accessory protein to direct the
trafficking of the EGF receptor to the focal complex as
well as stabilizes FAK within the complex [37,38]. In es-
sence, the phosphorylated form of caveolin-1 promotes
FAK phosphorylation and the turnover of focal com-
plexes [37,39]. Based on the potential interaction be-
tween phosphorylated caveolin-1 and the EGF receptor,
we performed EGF receptor immunoprecipitation (IP)
experiments to determine if phosphorylated caveolin-1
and the EGF receptor are associated in C. jejuni infectedcells (Figure 4). The experiment revealed that the EGF
receptor is activated, as judged by a significant increase
in the amount of the pEGF receptor, in C. jejuni-infected
HeLa cells compared to uninoculated cells. While we
predicted the previous result, unexpected was that the
treatment of cells with MβCD prevented both the activa-
tion of the EGF receptor by C. jejuni as well as the asso-
ciation of caveolin-1 with the EGF receptor.
Although it is known that the EGF receptor can be
stimulated in the absence of an extracellular ligand via
integrin signaling [40], we sought to determine whether
phosphorylated caveolin-1 participates in EGF receptor
activation. More specifically, we wanted to know if phos-
phorylated caveolin-1 directs the EGF receptor to the
sites containing activated α5β1-integrins. To address if
the association of the EGF receptor with the β1 integrin
can result in its activation in the absence of phosphory-
lated caveolin-1, HeLa cells were treated with caveolin-1
siRNA and infected with C. jejuni. The EGF receptor
antibody was then used for IP experiments. Blots were
probed with an antibody reactive against the β1 integrin
(Figure 5). The blots revealed that the β1 integrin co-
precipitated with the EGF receptor. Importantly, treat-
ment of the cells with caveolin-1 siRNA resulted in
greater than a 90% knockdown in caveolin-1 protein
compared with cells transfected with the scrambled
siRNA, as judged by immunoblot analysis coupled with
densitometry (not shown). These results demonstrated
Figure 4 Treatment of HeLa cells with MβCD disrupts C.
jejuni-dependent EGF receptor (EGFR) phosphorylation and
prevents EGFR association with caveolin-1. HeLa cells were
infected with C. jejuni with and without 5 mM MβCD treatment for
45 min. Panels: A) Cell lysates were immunoprecipitated (IP) with an
EGFR antibody, separated by SDS-PAGE, and blotted for pEGFR, total
EGFR, and caveolin-1. Lanes: 1, Uninfected cells (Cells only); 2,
Infected with C. jejuni in the absence of MβCD (vehicle only, water);
3, Infected with C. jejuni in the presence of 5 mM MβCD. Also shown
are the blots of the IgG isotype control IP probed with EGFR and
caveolin-1 antibodies. B) Quantification of band intensity of pEGF
receptor from three independent experiments. The asterisk indicates
P < 0.01 by Student’s t test.
Figure 5 C. jejuni induces the association of β1 integrin and
EGF receptor (EGFR) independent of caveolin-1. HeLa cells were
treated with caveolin-1 (Cav-1) siRNA and scrambled (Scr) siRNA. The
cells were infected with C. jejuni and incubated for 30 min. A portion
of the whole cell lysate (WCL) was probed for actin (loading control)
and caveolin-1 to determine the efficacy of the siRNA treatment (top
two blots). The EGFR was then immunoprecipitated (IP) from the
WCL, separated by SDS-PAGE, and blotted for EGFR and β1 integrin.
The EGFR coprecipitated with the β1 integrin following C. jejuni
infection. This association was not disrupted following caveolin-1
knockdown. Also shown is a blot of the IgG isotype control IP
probed with an antibody reactive against the β1 integrin.
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vation of the EGF receptor, via its association with the
activated β1 integrin, in the presence or absence of phos-
phorylated caveolin-1.
Only the phosphorylated form of caveolin-1 is associated
with components of the focal complex [39]. Given that we
observed that the EGF receptor pulls down caveolin-1 by
IP (Figure 4), we performed experiments to determine if C.
jejuni infection of HeLa cells would result in the activation
(phosphorylation) of caveolin-1, and if it did, the mechanis-
tic basis of the activation. It is known that caveolin-1 is
phosphorylated on Tyr-14 by c-Src [34]. We hypothesized
that the activation of the EGF receptor and FAK, which re-
sults following C. jejuni infection due to the activation of β1integrins, induces c-Src activity and the phosphorylation of
caveolin-1. To test our hypothesis, HeLa cells were treated
with specific inhibitors of EGF receptor (erlotinib), FAK
(TAE 226), and c-Src (PP2) activation. HeLa cells were in-
fected with C. jejuni, and EGF receptor IP experiments per-
formed (Figure 6). The blots were then probed with an
antibody reactive against the pEGF receptor and phos-
phorylated caveolin-1. Treatment of C. jejuni-infected
HeLa cells with the FAK and c-Src inhibitors reduced the
total level of the activated (phosphorylated) EGF receptor
(Figure 6, Panels A and B). In addition, the level of phos-
phorylated caveolin-1 associated with the EGF receptor in
C. jejuni-infected cells was significantly reduced when the
cells were treated with drugs that prevented FAK, EGF
receptor, and c-Src activity (Figure 6, Panels A and B).
Additionally, IP experiments were performed with FAK to
demonstrate drug efficacy on inactivation of FAK phos-
phorylation. Together, these data indicate that the phos-
phorylation of caveolin-1 occurs via c-Src, which is
activated by FAK and the EGF receptor (Figure 6, Panel
C). These findings are consistent with our current under-
standing of the signaling events required to direct proteins
to the focal complex [34,37].
Part III. C. jejuni cell invasion is not dependent on
caveolin-1
Caveolin-1 is not required for C. jejuni invasion of HeLa
epithelial cells
To further address the contribution of caveolin-1 and cave-
olae in C. jejuni internalization, HeLa cells were treated
Figure 6 Treatment of HeLa cells with inhibitors of the EGF receptor (EGFR), FAK, and c-Src activation disrupts C. jejuni-dependent EGF
receptor and caveolin-1 phosphorylation. HeLa cells were untreated or treated with inhibitors to FAK (5 μM TAE 226), EGFR (20 μM erlotinib),
c-Src (10 μg/ml PP2), and both FAK and EGFR inhibitors, as indicated in the figure. Positive and negative controls consisted of C. jejuni infected
and uninfected cells. Panels: A) Cell lysates were immunoprecipitated with either an EGFR antibody or a FAK antibody, separated by SDS-PAGE,
and blotted for total EGFR (loading control), pEGFR, FAK, pFAK, and pCaveolin-1. Lanes: 1, Infected with C. jejuni in the absence of any inhibitor
(vehicle only); 2, Treated with TAE 226 and infected with C. jejuni; 3, Treated with erlotinib and infected with C. jejuni; 4, Treated with PP2 and in-
fected with C. jejuni; 5, Treated with both TAE 226 and erlotinib and infected with C. jejuni; 6, Uninfected cells (Cells only). Also shown are the
blots of the IgG isotype control IP probed with caveolin-1, EGFR, and FAK antibodies. B) Quantitation of pEGFR and pCaveolin-1 from three
independent experiments. The asterisk indicates P≤ 0.05 as judged by one-way ANOVA followed by post-hoc Tukey’s analysis. Each error bar
represents ± the standard deviation of the mean (SD). C) The data indicates that caveolin-1 is phosphorylated by c-Src, which is stimulated in
response to the activation of FAK and the EGFR (Panel C).
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down of caveolin-1 protein in HeLa cells transfected with
caveolin-1 siRNA was confirmed by immunoblot analysis
coupled with densitometry. Knockdown of caveolin-1 pro-
tein in cells had no effect on C. jejuni internalization;
however, MβCD pretreatment prevented C. jejuni internal-
ization in caveolin-1 siRNA treated cells (Figure 7). We
then examined the ability of C. jejuni to induce membrane
ruffling in HeLa cells treated with caveolin-1 siRNA. Focal
adhesion kinase (FAK) was also targeted as a control, as
FAK is necessary for the downstream signaling events re-
quired for C. jejuni-induced membrane ruffling and intern-
alization [19]. FAK activation was inhibited by the
treatment of HeLa cells with TAE 226. In accordance with
the results of the internalization assay, scanning electron
microscopy examination revealed that the amount of mem-
brane ruffling induced by C. jejuni was indistinguishable in
the caveolin-1 siRNA treated versus the untreated HeLa
cells (62% versus 65%, respectively) (Figure 8). In contrast,
the treatment of HeLa cells with TAE 226 significantly re-
duced the level of C. jejuni-induced membrane ruffling
(35% versus 65%, respectively). These data support the hy-
pothesis that C. jejuni utilizes components of the focal
complex (i.e., FAK) to invade epithelial cells [19]. WeFigure 7 Knockdown of endogenous caveolin-1 protein does
not alter C. jejuni-invasion of HeLa cells. Panels: A) Internalization
of C. jejuni in HeLa cells transfected with caveolin-1 (Cav-1) or scrambled
(Scr) siRNA. Also shown is the number of bacteria internalized in HeLa
cells transfected with caveolin-1 siRNA and treated with 5 mM of
methyl-β-cyclodextrin (MβCD). The values represent the mean number
of internalized bacteria ± standard deviation. The asterisks indicate
significance between untreated and treated samples (P < 0.05), as
determined using Student’s t test. B) Whole cell lysates of untreated
(vehicle only), caveolin-1 siRNA transfected, and Scr siRNA transfected
HeLa cells probed with an α caveolin-1 antibody. The blot was
re-probed with an α actin antibody to confirm that equal amounts of
protein were loaded into each well.concluded that C. jejuni invasion of host cells is independ-
ent of caveolae based on the following two observations: a)
caveolin-1 siRNA treatment of HeLa cells had no effect on
C. jejuni internalization; and b) caveolin-1 siRNA treatment
of HeLa cells did not block C. jejuni-induced membrane
ruffling.
C. jejuni invade Caco-2 cells
Caveolin-1 and caveolin-2 are synthesized in a wide var-
iety of tissues [13]. Although their precise function is
not clear, caveolae are involved in a number of import-
ant cellular processes, including signal transduction, cal-
cium signaling, and endocytosis [9]. To address the
question of whether caveolae are required for C. jejuni
internalization in a different manner, we took advantage
of the fact that these structures are not present in all cell
types. Since caveolin-1 is essential for caveolae forma-
tion, cells lacking this protein do not have caveolae [13].
Consistent with previous reports [7,9,12], a 22 kDa band,
corresponding to the Mr of caveolin-1, was detected in
HeLa and INT 407 cells but not in Caco-2 cells, as
judged by immunoblot analysis using a caveolin-1 spe-
cific antibody (Additional file 7: Figure S7). Others have
also been unable to detect caveolin-2 in Caco-2 cells
[7,12]. Thus, Caco-2 cells do not have caveolae. We then
performed an experiment to examine the effect of
MβCD on C. jejuni internalization of Caco-2 cells. Inter-
estingly, treatment of Caco-2 cells with MβCD reduced
C. jejuni internalization in a dose-dependent manner
(Additional file 8: Figure S8). These results demonstrate
that MβCD inhibits C. jejuni internalization regardless
of whether the cells possess caveolae structures/caveo-
lin-1. Noteworthy is that MβCD has been reported to
disrupt all lipid rafts [41].
Transfection of Caco-2 cells with a plasmid that ex-
presses caveolin-1 cDNA results in the proper localiza-
tion of caveolin-1 and the formation of caveolae [9].
Based on the sum of the data, the investigators con-
cluded that caveolin-1 in Caco-2 cells behaves similar to
caveolin-1 expressed in cells that normally express the
protein [9]. To determine if the presence of caveolae
might potentiate the number of C. jejuni internalized,
binding and internalization assays were performed with
Caco-2 cells that were transfected with a plasmid ex-
pressing caveolin-1 (Additional file 9: Figure S9). No dif-
ference was observed in the number of C. jejuni
internalized in Caco-2 expressing caveolin-1 versus the
control cells (i.e., Caco-2 cells transfected with a plasmid
without an insert). Importantly, caveolin-1 was detected
only in the Caco-2 cells transfected with the caveolin-1
containing plasmid, as judged by immunoblot analysis
with a caveolin-1 specific antibody.
An alternative approach to expressing caveolin-1 in
cells that normally do not express the protein and have
Figure 8 Knockdown of endogenous caveolin-1 protein does not alter C. jejuni-induced membrane ruffling as judged by scanning
electron microscopy (SEM). HeLa cells were transfected with caveolin-1 siRNA or scrambled (Scr) siRNA, infected with C. jejuni for 15 min, and
processed for examination by SEM as outlined in ‘Methods.’ The images shown are uninfected HeLa cells (Panels A and F) and C. jejuni infected
HeLa cells (Panels B-E and G-J) that are untreated (Panels B and G), treated with caveolin-1 siRNA (Panels C and H), scrambled (Scr) siRNA
(Panels D and I), or with the FAK inhibitor TAE 226 (Panels E and J). Arrows indicate C. jejuni associated with the host cells. Also indicated is the
percentage of cells with membrane ruffling of total cells (N). In contrast to the C. jejuni infected cells in the absence of an inhibitor, C. jejuni
infected cells treated with caveolin-1 siRNA, and C. jejuni infected cells treated with Scr siRNA, treatment of cells with the FAK inhibitor TAE 226
inhibited C. jejuni-induced membrane ruffling. The images shown in Panels A-E were collected at the same magnification and the images shown
in Panels F-J were collected at the same magnification.
Konkel et al. Cell Communication and Signaling 2013, 11:100 Page 9 of 17
http://www.biosignaling.com/content/11/1/100no caveolae is to use caveolin-1 knockout cells. More
specifically, the 3T3 mouse embryonic fibroblast knock-
out cell line (3T3 MEF KO, CRL-2753) is homozygous
for disruption of the caveolin-1 gene (Cav-1−/−) whereas
the 3T3 MEF wild-type cell line (3T3 MEF WT, CRL-
2752) is Cav-1+/+. We performed C. jejuni binding and
internalization with the 3T3 MEF WT and 3T3 MEF KO
cells (Additional file 10: Figure S10). We did not observe
a difference in the numbers of C. jejuni bound to or in-
ternalized in the 3T3 MEF WT versus the 3T3 MEF KO
cells. Taken together, these results are consistent with
the proposal that C. jejuni invasion of host cells occurs
in a caveolae-independent manner.
MβCD treatment of HeLa cells disrupts β1 integrin and EGF
receptor association
To address the findings of previous reports, we per-
formed experiments to determine the mechanistic basis
for MβCD inhibition of C. jejuni internalization. We hy-
pothesized that MβCD prevents the host signaling re-
sponse triggered by C. jejuni infection, thereby resulting
in a decrease in internalized bacteria, based on the fol-
lowing observations: a) treatment of cells with MβCD
disrupts all lipid rafts [41]; b) a substantial amount of
the EGF receptor is localized to lipid rafts, but not to
caveolae [42]; c) activation of the EGF receptor (phos-
phorylation of residues Tyr-845, Tyr-1068, Tyr-1086 andTyr-1173) can be activated in the absence of EGF by its
association with the β1 integrin (ligand independent acti-
vation) [40]; and d) β1 integrin localization (raft-me-
diated endocytosis) is sensitive to cholesterol depletion
(i.e., MβCD treatment of cells) [43]. Noteworthy is that
we have shown that C. jejuni infection of cells results in
β1 integrin and EGF receptor association (Figure 5) and
EGF receptor activation (Figure 4). Thus, we specifically
tested if MβCD treatment of HeLa cells disrupts β1 in-
tegrin and EGF receptor association. The results of this
experiment revealed that MβCD completely inhibited
EGF receptor activation and disrupted the association of
the β1 integrin and EGF receptor, as judged by IP ex-
periments (Figure 9). HPβCD treatment of HeLa cells
also inhibited EGF receptor activation and disrupted
the association of the β1 integrin and EGF receptor
(Additional file 11: Figure S11), and MβCD treatment of
Caco-2 cells (caveolin-1 negative) prevented EGF recep-
tor activation (Additional file 12: Figure S12). These
findings provide a plausible explanation for the inhibi-
tory effect of MβCD on C. jejuni internalization.
Discussion
Caveolae are flask-like structures that are enriched in
cholesterol and glycosphingolipids; however, caveolae are
different from planar lipid rafts based on the presence of
the cholesterol-binding protein caveolin-1. Caveolin-1
Figure 9 Treatment of HeLa cells with methyl-β-cyclodextrin
(MβCD) disrupts the C. jejuni-dependent association of
phospho-EGF receptor (pEGFR) with β1 integrin. HeLa cells were
infected with C. jejuni in the presence and absence of 5 mM MβCD
for 45 min. Panels: A) Cell lysates were immunoprecipitated with an
EGFR antibody, separated by SDS-PAGE, and blotted for β1 integrin,
pEGFR, and total EGFR (loading control). HeLa cells were uninfected
(Lanes 1 and 3) or C. jejuni infected (Lanes 2 and 4) in the absence
(Lanes 1 and 2) or presence of MβCD (Lanes 3 and 4). Also shown
are the blots of the IgG isotype control IP probed with an antibodies
reactive against the EGFR and the β1 integrin. B) Quantification of
band intensity of β1 integrin and pEGFR from three independent
experiments. The asterisk indicates P < 0.01 by one-way ANOVA
followed by post-hoc Dunnet’s analysis.
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Regardless of the specific type of lipid raft, these regions
provide a spatial and temporal meeting site for signaling
molecules, thus serving as signaling platforms [8].
A number of bacteria, including Campylobacter jejuni
and Salmonella enterica serotype Typhimurium, have
been proposed to require caveolae for cell invasion
based on the observation that treatment of cells with fili-
pin III or MβCD blocked bacterial internalization in adose-dependent manner [15,17,44]. Wooldridge et al.
[15] observed a dose-dependent reduction in C. jejuni
invasion of Caco-2 cells when the cells were treated with
filipin III, and concluded that caveolae are involved in C.
jejuni uptake. Subsequently, Watson and Galan [45] re-
ported that the treatment of human T84 cells with
MβCD blocked C. jejuni internalization. However, based
on additional assays, Watson and Galan [45] speculated
that C. jejuni internalization might not be associated
with caveolae-mediated endocytosis, but that that caveo-
lae or caveolin-1 may play a role in the host cell signal-
ing events necessary for bacterial uptake. Our data
indicate that C. jejuni internalization occurs in a
caveolae-independent manner. We did find that treat-
ment of HeLa cells with MβCD and HPβCD, two
cholesterol-depleting compounds, reduced C. jejuni in-
ternalization in a dose-dependent manner. These results
support the hypothesis that C. jejuni internalization oc-
curs in a caveolae-dependent manner, as caveolin-1 is a
cholesterol binding protein and the treatment of cells
with a cholesterol-depleting compound would disrupt
the cellular localization of caveolin-1. However, knock-
down of caveolin-1 protein in HeLa cells by treatment
with caveolin-1 siRNA had no effect on C. jejuni intern-
alization. In addition, treatment of Caco-2 cells with
MβCD inhibited C. jejuni internalization (Additional
file 8: Figure S8). Caco-2 cells do not express caveolin-1
and, as a consequence, do not have caveolae (Additional
file 7: Figure S7) [9,12]. We expressed caveolin-1 in
Caco-2 cells to attempt to enhance the invasiveness of
C. jejuni, but did not observe a change in the number of
C. jejuni internalized versus Caco-2 cells transfected
with a plasmid without an insert (caveolin-1 negative
cells) (Additional file 9: Figure S9). Consistent with this
finding, the number of C. jejuni bound to and internal-
ized in 3T3 MEF Cav-1+/+ cells was not different from
that of 3T3 MEF Cav-1−/− cells (Additional file 10:
Figure S10). We further demonstrated that MβCD and
HPβCD disrupts the interaction between EGF receptor
and the β1 integrin, which explains the mechanistic basis
for the inhibition of C. jejuni internalization with this in-
hibitor (Figure 9 and Additional file 11: Figure S11).
Taken together, our findings show that MβCD does not
specifically target and disrupt the function of caveolae; it
disrupts all lipid rafts and blocks the outside-in signaling
that C. jejuni induces from binding to fibronectin. Also
worth mentioning is that caveolin-containing vesicles
do not contain markers of early endosomes, such as
the early endosome marker EEA-1, lysosomes, ER or
Golgi [46,47]. However, researchers have found that the
Campylobacter-containing vacuoles (CCVs) contain markers
of both early and late endosomes [45,48]. More specifically,
CCVs display EEA-1, and then acquire the Rab5
and Rab7 GTPases as well as the lysosomal-associated
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in the process of internalization are associated with the cell
adhesion proteins paxillin and vinculin (Additional file 5:
Figure S5 and Additional file 6: Figure S6), which is con-
sistent with the mechanism of receptor-mediated en-
docytosis. In summary, we show that the long-standing
conclusion that C. jejuni invades via caveolae is inaccurate.
Nethe and Hordijk [34] concluded that caveolin-1, in
general, serves as a negative regulator of cell signaling.
However, the phosphorylated form of caveolin-1 (caveo-
lin-1 pTyr-14), which is excluded from caveolae, can
interact with various components of the focal complex,
including FAK, the β1 integrin, and phosphorylated pax-
illin [39]. The phosphorylated from of caveolin-1 is also
known to stabilize the localization of FAK within the
focal complex resulting in the recruitment of p130Cas
and paxillin that promote focal complex turnover [37].
Our data indicate that the integrins and EGF signaling
pathway act in a cooperative manner to promote C.
jejuni internalization. Although the EGF receptor is acti-
vated by binding of an extracellular ligand, it can be
activated in the absence of an extracellular ligand via in-
tegrin signaling. In the case of integrin-dependent EGF
receptor-phosphorylation, activation is dependent upon
a multimeric complex of integrins, c-Src, p130Cas and
the EGF receptor [40]. Activation of the EGF pathway
alters components of the cytoskeleton involved with
actin organization, focal adhesion formation and reso-
lution, as well as cell-cell adhesion [49]. We had previ-
ously found that pre-treatment of INT 407 cells with
PD168393 and erlotinib, which are specific inhibitors of
EGF receptor tyrosine phosphorylation, significantly
inhibited C. jejuni-mediated host cell membrane ruffling
and invasion [19]. We had also found that the EGF re-
ceptor becomes phosphorylated at sites Tyr-845 and
Tyr-1068 upon infection with C. jejuni, which is consist-
ent with the idea that the EGF receptor is stimulated via
integrin signaling (residues Tyr-845, Tyr-1068, Tyr-1086
and Tyr-1173) [40]. Noteworthy is that pre-treatment of
INT 407 cells with EGF rescues the invasiveness of a
non-invasive C. jejuni mutant [19]. Here we report that
infection of HeLa cells with C. jejuni induces EGF recep-
tor activation, as evidenced by an increase in the level of
phosphorylated EGF receptor when compared to unin-
fected cells. We have also found that pre-treatment of
HeLa cells with MβCD disrupts C. jejuni-dependent
EGF receptor phosphorylation. Our findings are consist-
ent with reports showing that the EGF receptor is local-
ized in lipid rafts, but not in caveolae [42,50].
To dissect the relationship between Rac1 activity and
the involvement of actin in C. jejuni internalization,
HeLa cells were treated with cytochalasin D prior to in-
fection. Cytochalasin D depolymerizes actin filaments by
binding to the (+) end of F-actin, thereby blocking theaddition of G-actin subunits to these sites [51]. We
found that the treatment of HeLa cells with cytochalasin
D had no affect on Cia protein delivery or Rac1
activation (which must occur prior to microfilament
re-organization), but prevented C. jejuni-induced mem-
brane ruffling (Figures 2 and 3). This finding is consist-
ent with previous work demonstrating the involvement
of microfilaments (MFs) in C. jejuni internalization [20]
and our model in which we propose that C. jejuni-host
cell contact and the delivery of the Cia proteins to the
host cell cytosol promotes the activation of focal com-
plex components and Rac1.
While previous studies have shown that C. jejuni
internalization is sensitive to microtubule inhibitors
[52,53], the role of microtubules (MTs) in C. jejuni inva-
sion has not been clear. To gain insight into the poten-
tial role of microtubules in C. jejuni invasion, we treated
HeLa cells with nocodazole. This drug binds β-tubulin,
preventing tubulin polymerization [25]. We found that
the treatment of HeLa cells with nocodazole had no
affect on Cia protein delivery, but prevented both Rac1
activation and C. jejuni-induced membrane ruffling
(Figures 2 and 3). One possible reason that nocodazole
treatment reduces C. jejuni internalization is that MTs
and MFs act cooperatively in recycling integrin receptors
[54,55]. Alternatively, nocodazole could reduce the num-
ber of C. jejuni internalized by preventing the disassem-
bly of focal adhesions [56]. Importantly, focal complexes
and focal adhesions are two related types of cellular at-
tachment complexes that differ in their molecular com-
position and the rate of association versus dissociation
of their molecular components. Focal complexes are
transient attachments that form at the tip of a cellular
protrusion whereas focal adhesions are larger, longer-
lived attachments from which stress fibers organize.
Treatment of cells with low concentrations of noco-
dazole results in enlarged focal adhesions. Moreover,
nocodazole reduces Rac1 membrane targeting and acti-
vation, thereby slowing the turnover of focal complexes
[8,54,57]. We favor a model whereby the treatment of
HeLa cells with nocodazole reduces the total number
of dynamic structures that are involved in C. jejuni
internalization (focal complexes), which in turn inhi-
bits Rac1 recruitment, Rac1 activation, actin rearrange-
ment, and membrane ruffling. In essence, nocodazole
and MβCD inhibit the cell signaling events necessary to
initiate cytoskeletal rearrangement, whereas cytochalasin
D blocks cytoskeletal rearrangement by preventing actin
polymerization.
Conclusion
Based on published data and the findings herein, a re-
fined model of C. jejuni invasion can be generated where
the internalization of C. jejuni by epithelial cells is
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involves cholesterol-rich (non-caveolae) lipid raft do-
mains in the host plasma membrane (Figure 10). Activa-
tion of the α5β1 integrins by C. jejuni binding to
fibronectin results in outside-in signaling, resulting in
FAK and EGF receptor activation. The activation of FAK
promotes paxillin and Src activation. The activation of
the EGF receptor and Src results in the phosphoryla-
tion of caveolin-1, which associates with the EGF re-
ceptor. Paxillin serves as a point of convergence, where
integrin-dependent signals from the ECM trigger intra-
cellular signal transduction involved in actin rearrange-
ment. The phosphorylation of paxillin at Tyr-31 and
Tyr-118 by the FAK-Src complex creates binding sites
on paxillin for p130Cas and the Crk family of adaptor
proteins, which in turn activate Rac1 via the CrkII/
DOCK180/ELMO complex. Noteworthy is that a C.
jejuni CiaC secreted protein is, in part, responsible for
Rho GTPase Rac1 recruitment and activation, as judged
by immuno-fluorescence microscopy and activated Rac1
G-LISA™, respectively. We have also shown that Erk 1/2
and cortactin activation are required for membrane ruf-
fling downstream of activated Rac1 [58,59]. Our data
shows that caveolin-1 is not required for C. jejuni in-
ternalization, but it is associated with components of the
focal complex following C. jejuni-induced activation of
the EGF receptor and FAK via α5β1 integrin receptorFigure 10 Comprehensive model of C. jejuni internalization. The activa
infection via the activation of the α5β1 integrins, induces c-Src activity and
recruitment of key components of the focal complex (i.e., FAK, paxillin, vinc
assembly promotes the activation of Erk 1/2, Rac1, Cdc42, cortactin, and N-stimulation. Our data further indicate that activation of
FAK and the EGF receptor triggers the activation of
c-Src, which then acts to phosphorylate caveolin-1. Fi-
nally, we present a plausible explanation for why MβCD,
cytochalasin D, and nocodazole treatment of epithelial
cells reduces the internalization of C. jejuni. Together,
these findings provide new insight into the mechanism
that C. jejuni utilizes to invade epithelial cells.
Methods
Bacterial strains
The C. jejuni wild-type F38011 strain was grown in
Mueller-Hinton (MH) broth, on MH agar plates con-
taining 5% citrated bovine blood (MH-blood), or in bi-
phasic cultures (10 ml of MH broth overlaid on a MH
agar plate) in a microaerobic atmosphere (5% O2, 10%
CO2, 10% H2, 75% N2).
Tissue culture
HeLa (ATCC® CCL2™), Caco-2 (ATCC® HTB-37™), 3T3
MEF WT (ATCC® CRL-2752™), and 3T3 MEF KO
(ATCC® CRL-2753™) cells were purchased from the
American Type Culture Collection (Manassas, VA) and
were grown in Minimal Essential Medium (MEM) sup-
plemented with 10% (vol/vol) fetal bovine serum (FBS,
Hyclone Laboratories Inc., Logan, UT) and 5% L-glu-
tamine (1.8 mM). The cells were incubated at 37°C in ation of the EGF receptor and FAK, which results following C. jejuni
the phosphorylation of caveolin-1. Uptake of C. jejuni requires the
ulin, p130Cas, the CrkII/DOCK-180/ELMO complex). Focal complex
WASP leading to actin cytoskeletal reorganization.
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72 h.Inhibitors
The stock inhibitors used in this study were prepared as
indicated. Methyl-β-cyclodextrin (MβCD) (500 mM),
HPβCD (500 mM), and erlotinib (20 mM) were prepared
in water. Filipin III (1 mM), nystatin (50 mg/ml), noco-
dazole (2 mM), cytochalasin D (100 mM), and PP2
(10 mg/ml) were prepared in DMSO. TAE 226 (1 mM)
was prepared in methanol.C. jejuni-cell infection assays
C. jejuni binding and internalization assays were per-
formed with HeLa, Caco-2, and 3T3 MEF cells as out-
lined previously [60]. All assays were performed at a
multiplicity of infection (MOI) ranging between 50 and
500, and repeated a minimum of 3 times to ensure re-
producibility. The reported values represent the mean
counts ± standard deviations derived from quadruplicate
wells.
To test the effect of MβCD, HPβCD, filipin III, and nysta-
tin on C. jejuni cell invasion, HeLa cells were pre-treated
for 30 min in MEM containing a range of concentrations of
the inhibitors. Following incubation, a suspension of C.
jejuni in MEM was added to each well and binding and in-
ternalization assays were performed using standard labora-
tory protocols. To determine if an inhibitor or the vehicle
(water or DMSO) had an effect on the viability of HeLa
cells, the cells were rinsed twice with PBS following inhibi-
tor treatment, stained with 0.5% trypan blue for 5 min, and
visualized with an inverted microscope. To determine the
specificity of MβCD treatment, cholesterol was restored to
the membrane as described previously [61]. Briefly, cyclo-
dextrin:cholesterol complex was formed at a cyclodextrin:
cholesterol molar ratio of 8:1. The HeLa cells were treated
with 5 mM MβCD for 30 min and then the cyclodextrin:
cholesterol complex was added at 5 mM for an additional
30 min prior to infection with C. jejuni.Scanning electron microscopy
Scanning electron microscopy was performed as de-
scribed previously [19]. Briefly, HeLa cells were pre-
treated with MβCD (5 mM), nocodazole (20 mM), and
cytochalasin D (1 mM), for 30 minutes prior to inocula-
tion with C. jejuni. EGF (100 ng/ml) was added to cells
5 min prior to inoculation with C. jejuni. Quantification
of membrane ruffling was done by two independent ob-
servers and tabulated. Only cells with clear boundaries
were counted and cells positive for membrane ruffling
were scored.Adenylate cyclase domain (ACD) reporter delivery assays
The delivery of the C. jejuni CiaC protein to HeLa cells
was determined using laboratory established protocols
[27]. We used the adenylate cyclase domain (ACD) of
the Bordetella pertussis CyaA protein fused to the C.
jejuni CiaC protein as a reporter for protein delivery to
host cells [62-64]. ACD catalyzes the production of
cAMP from ATP only in the presence of the host cell
protein calmodulin. As a negative control, the metK
gene driven from its native promoter was also cloned in-
frame with the ACD. The C. jejuni MetK protein is a
cytosolic S-adenosylmethionine synthetase [29]. Briefly,
HeLa cells were pre-treated with MβCD (5 mM), noco-
dazole (20 mM), cytochalasin D (1 mM), TAE 226 (5
μM), and DMSO (vehicle only control) for 30 minutes
prior to inoculation with C. jejuni. The amount of intra-
cellular cAMP produced in HeLa cells was assayed
at 30 min post-infection by ELISA (Assay Designs,
Farmingdale, NY). The assay was repeated 5 times to
ensure reproducibility.
Assessment of Rho GTPase Rac1 activation
HeLa cells were seeded into 6 well tissue culture plates
at a density of 2 × 105 cells/well and serum starved for
24 hours. Cells were pre-treated with vehicle (DMSO),
MβCD (5 mM), nocodazole (20 mM), and cytochalasin
D (1 mM) for 30 minutes prior to inoculation with C.
jejuni resuspended in PBS. The amount of activated
Rac1 in C. jejuni-infected and uninfected cells was de-
termined using the G-LISA™ Rac1 Activation Assay ac-
cording to the manufacturer’s instructions (Cytoskeleton,
Denver, CO).
Transfection of cells with small interfering RNA (siRNA)
or plasmids
HeLa cells were transfected with small interfering RNA
(siRNA) using lipofectamine RNAiMax (Invitrogen, Grand
Island, NY) according to the manufacturer’s instructions.
Caveolin-1 stealth siRNA (Invitrogen, 21244939) and
scrambled control siRNA (Santa Cruz Biotechnology, Inc.,
CA, sc-37007) were applied to the cells 24 h before the
assay. A standard binding and internalization assay was
then performed. Knockdown of endogenous proteins was
confirmed by immunoblot with antibodies for specific host
proteins. Caco-2 cells were transfected with plasmids en-
coding for caveolin-1-eGFP or the empty vector control
eGFP using Lipofectamine LTX and Plus™ Reagent accord-
ing to manufacturer’s instructions (Invitrogen, 15338–100)
Immunoprecipitation
HeLa cells were seeded at 3 × 106 cells/well and serum
starved in MEM for 3 h prior to the addition of C. jejuni
with and without treatment as well as an uninfected (nega-
tive control). Cells were pretreated 30 min prior to and
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erlotinib, and/or 5 μM TAE 226, or with 5 mM MβCD
added at the time of infection. At 45 min following infec-
tion, cells were collected in ice-cold lysis buffer [10 mM
Hepes, 10% glycerol, 50 mM sodium fluoride, 150 mM so-
dium chloride, 1% Triton X-100, 20 μg/ml DNAse (Sigma,
D5025), Protease Inhibitor Cocktail (Sigma, P2714), 1 mM
phenylmethylsulfonyl fluoride (PMSF), and 1 mM sodium
orthovanadate]. Immunoprecipitations were performed by
incubating cell lysates with either an anti-FAK antibody
(610087, BD Biosciences, San Jose, CA) or an anti-EGF re-
ceptor mAb 528 antibody (Santa Cruz, sc-120) at 4°C over-
night and then adding protein A/G beads at 4°C for 1 h
with rotation. The bead complexes were washed and dis-
solved in sample buffer. Blots were probed with an antibody
that reacts against the active forms of FAK (pFAK Y-925,
Cell Signaling, 3284) and the EGF receptor (pEGFR Y-1068,
Cell Signaling Technology, Inc., Danvers, MA). Blots were
also probed with an antibody that reacts against FAK (Santa
Cruz, 557), the EGF receptor (Santa Cruz Biotechnology,
sc-03), caveolin-1 (Cell Signaling Technology, Inc., Danvers,
MA), and pCaveolin-1 (BD Biosciences). The reactive
bands were detected using the enhanced chemilumines-
cence (ECL) Prime system (GE Healthcare Biosciences,
Piscataway, NJ) coupled with a GE LAS-4000 mini.
Densitometry was performed using Fujifilm Multi Gauge
software (Fujifilm, Valhalla, NY). The intensity of each band
was obtained by subtracting the average background from
adjacent areas in each lane from the total level of the ap-
propriate molecular weight. Each of these values was then
normalized to the cells only negative control.
Preparation of whole cell lysates
Whole cell lysates (WCLs) of HeLa and Caco-2 cells
were prepared by the addition of lysis buffer, as de-
scribed above. The lysates were collected and analyzed
by SDS-PAGE coupled with immunoblot analyses. The
protein concentration of each supernatant was deter-
mined by the bicinchoninic acid (BCA, Pierce, Rockford,
IL) protein assay and normalized prior to performing
SDS-PAGE.
SDS-polyacrylamide gel electrophoresis (PAGE) and
immunoblot analysis
WCLs were subjected to SDS-PAGE and transferred to
polyvinylidene fluoride membranes (PVDF; Immobilon
PSQ; Millipore Corp., Bedford, MA) for immunoblot ana-
lysis [65]. The following antibodies were used for immu-
noblot analysis: goat α actin polyclonal antibody (Santa
Cruz, sc-1616), rabbit α caveolin-1 XP® monoclonal anti-
body (Cell Signaling Technology, 3267), mouse α caveolin-
1 (pTyr-14) (BD Transduction Laboratories, 611338), rabbit
α EGF receptor polyclonal antibody (Santa Cruz, sc-03),
rabbit α phospho-EGF receptor (Tyr-1068) monoclonalantibody, (Cell Signaling Technology, 3777), rabbit α FAK
(Santa Cruz, sc-557), rabbit α phospho-FAK (Y925) (Cell
Signaling Technology, 3284) and rabbit α β1 integrin poly-
clonal antibody (Cell Signaling Technology, 4706). The sec-
ondary antibodies used in this study were: goat α rabbit
IgG (Sigma, A6154), rabbit α goat IgG (Sigma, A5420), and
goat α mouse IgG (Sigma, A4416).
Immunofluorescence microscopy
HeLa cells were plated on 22 mm2 glass coverslips at
50% confluence and cultured overnight, and then treated
with either 5 mM of MβCD or solvent without drug for
75 minutes. The 75 min time point encompasses the
normal assays that used a 30 min pre-treatment with in-
hibitor and the 45 min infection period with C. jejuni
and the inhibitor. Cells were rinsed with PBS, fixed with
4% methanol-free paraformaldehyde (Pierce Biotechnol-
ogy, Inc, #PI-28906) in PBS for 20 minutes, rinsed, and
then incubated with a rabbit polyclonal anti-caveolin
antibody (BD Biosciences #610059) at a dilution of 1:100
in PBS containing 0.1% Tween 20 and 0.02 mg/ml so-
dium azide (PBS-TW) for three hours at room tempera-
ture. After rinsing in PBS-TW, the cells were incubated
for two hours at room temperature with FITC labeled
goat anti-rabbit secondary antibody (Jackson Immuno-
Chemicals #111-096-047) at a dilution of 1:200 in PBS
TW containing 0.025 mg/ml rhodamine-labeled phal-
loidin (SigmaAldrich #P-1951). After a final rinse, co-
verslips were mounted in medium consisting of 90%
glycerol, 10% 10X PBS and 1% DABCO and preparations
sealed with nail polish. Cells were viewed with a Leica
SP5 confocal microscope using a 63X 1.4 NA objective
lens and a pinhole set to an Airy unit size of 1 and a
pixel size of 60 nm. Detector gain settings were opti-
mized for imaging of control cells and left at this setting
for imaging of MβCD treated cells. Images shown are
single confocal sections and are representative of at least
three full field images of cell monolayers showing more
than 100 cells per image.
HeLa cells were incubated with C. jejuni for 45 min at
37°C in a 5% CO2 incubator prior to fixing with 3.7%
paraformaldehyde for 15 min. C. jejuni were stained with
a 1° rabbit α C. jejuni antibody and a 2° Texas Red dye-
conjugated donkey α-rabbit antibody (Jackson Immunore-
search Labs, West Groves, PA). Paxillin and vinculin were
detected using a mouse α paxillin polyclonal antibody
(Product #610052, BD Transduction Laboratories™) and a
mouse IgG1 α vinculin monoclonal antibody (Product
#V9131, Sigma) followed by incubation with a goat IgG
(H+ L)-FITC labeled antibody (Boehringer Mannheim, In-
dianapolis, IN). The coverslips were mounted with 90%
glycerol plus 10% 10X PBS containing 1, 4-Diazabicyclo
[2.2.2]octane (DABCO™) as an antifading agent. Images
were obtained using a Leica TCS SP5 confocal microscope
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periments were repeated a minimum of three times and at
least 5 fields of view were observed to ensure reproducibil-
ity. The quantification of bacteria co-localization was per-
formed by assessing the number of bacteria that were in
direct contact with host cells (touching or within the de-
fined borders of the HeLa cells). Co-localization was de-
fined as any C. jejuni within the cell border that is in
contact with paxillin or vinculin. The interaction between
cell-associated C. jejuni and focal complexes was per-
formed from six randomly selected fields of cells in a total
of two trials were scored by a blinded investigator.
Statistical analysis
All data was evaluated using a Student’s t test or one-way
ANOVA followed by post-hoc Tukey’s analysis of the
means, using Prism 6 (GraphPad Software, La Jolla, CA).
Statistical significance was defined by a value of *P < 0.05.
Additional files
Additional file 1: Figure S1. C. jejuni internalization into HeLa cells treated
with methyl-β-cyclodextrin (MβCD) is recovered by cholesterol replenishment.
HeLa cells were treated with 5 mM MβCD for 30 min. Membrane cholesterol
was then replenished by treatment with cyclodextrin:cholesterol complex for
30 min prior to infection with C. jejuni. Panels: A) Host cell association was un-
affected by MβCD treatment and cholesterol replenishment. B) Treatment
with 5 mM MβCD significantly reduced C. jejuni internalization. Membrane
cholesterol restoration through cyclodextrin:cholesterol complex treatment re-
covered the invasion phenotype. The asterisk indicates a significant
reduction in C. jejuni internalization compared to cells infected with C. jejuni in
the absence of the inhibitor (vehicle), as judged by one-way ANOVA followed
by post-hoc Dunnets’s analysis (P< 0.05). Each error bar represents ± the
standard deviation of the mean (SD).
Additional file 2: Figure S2. Effects of methyl-β-cyclodextrin (MβCD)
treatment on caveolin-1 localization in HeLa cells. Cells shown were
labeled with anti-caveolin primary and fluorescein labeled secondary
antibodies (green) and counterstained with rhodamine-labeled phalloidin
to visualize filamentous actin (red). Vehicle treated cells (Panels A and C)
show abundant caveolin-1 in the vicinity of the cell boundary. Caveolin-1
was localized at or proximal to the cytoplasmic boundary of the actin
cytoskeleton underlying the cell plasma membrane (inset in Panel A and
arrows in Panel C), suggesting the caveolin-1 may be in the process of
recycling. In contrast, MβCD treated cells displayed fewer and smaller
sites of caveolin-1 staining (Panels B and D), and appeared more closely
associated with actin at the cell boundary (D). Bars are 10 microns (Panels
A and B) and 2 microns (Panels C and D).
Additional file 3: Figure S3. Treatment of HeLa cells with the cholesterol-
depleting compound hydroxypropyl-β-cyclodextrin (HPβCD) reduces C. jejuni
internalization. HeLa cells were treated with 2.5, 5.0, 7.5, 10, and 20 mM of
HPβCD for 30 min prior to inoculation with C. jejuni. The control consisted
of cells infected with C. jejuni in the absence of the inhibitor in medium
containing vehicle (i.e., water). Bars indicate the number of adherent (Panel A)
and internalized (Panel B) bacteria. The asterisk indicates a significant reduction
in C. jejuni internalization compared to cells infected with C. jejuni in the
absence of the inhibitor in medium alone, as judged by one-way ANOVA
followed by post-hoc Dunnets’s analysis (P< 0.05). Each error bar represents ±
the standard deviation of the mean (SD).
Additional file 4: Figure S4. Treatment of cells with the cholesterol
binding agents filipin III or nystatin had no effect on C. jejuni
internalization. HeLa cells were treated with a range of concentrations of
filipin III (Panel A) and nystatin (Panel B) for 30 min prior to inoculationwith C. jejuni. The control consisted of cells infected with C. jejuni in the
absence of the inhibitor in medium containing vehicle (i.e., DMSO)
(Panel C). Each error bar represents ± the standard deviation of the mean
(SD).
Additional file 5: Figure S5. Methyl-β-cyclodextrin (MβCD) treatment
of cells reduces the co-localization of C. jejuni with the focal complex
components paxillin and vinculin. HeLa cells were infected with C.
jejuni in the absence (Panels A and B) or presence of MβCD (Panels
C and D) and examined by confocal microscopy. Paxillin (Panels A
and C) and vinculin (Panels B and D) are shown in blue and C. jejuni
is shown in red. Also shown is an increased magnification of the
image (insert). Sites of co-localization observed in a given field are
indicated (arrows). In total, 42.0% of cell-associated C. jejuni were
co-localized with paxillin (N = 71 of 169) and 40.3% of cell-associated
C. jejuni were co-localized with vinculin (N = 64 of 159 total). Following
treatment with MβCD, 25.4% of cell-associated C. jejuni were co-localized
with paxillin (N = 33 of 130) and 24.7% of cell-associated C. jejuni were
co-localized with vinculin (N = 22 of 89 total). Scale bar is 10 microns for low
magnification images and 2 microns for the higher magnification images.
Additional file 6: Figure S6. Additional confocal microscopy images
showing C. jejuni associated with paxillin and vinculin. Paxillin (Panels A-
C) and vinculin (Panels D-F) are shown in blue and C. jejuni is shown in
red. Also shown is an increased magnification of each image (insert).
Scale bar is 10 microns for low magnification images and 2 microns for
the higher magnification images.
Additional file 7: Figure S7. Caveolin-1 is synthesized by human HeLa
and INT 407 epithelial cells but is not synthesized by human Caco-2
epithelial cells. Cell lysates from HeLa, INT 407, and Caco-2 cells were
prepared as described in the ‘Methods’ section. The blots were probed
with antibodies reactive against caveolin-1 and actin. The molecular
masses of the protein standards are listed in kDa.
Additional file 8: Figure S8. Treatment of Caco-2 cells with 1.25, 2.5,
5.0, and 7.5 mM of methyl-β-cyclodextrin (MβCD) reduces C. jejuni
internalization. The epithelial cells were treated with MβCD for 30 min
prior to inoculation with C. jejuni, as outlined in the ‘Methods’ section.
The control consisted of cells infected with C. jejuni in medium containing
the vehicle (water). Bars indicate the mean number of internalized bacteria.
The asterisks indicate a significant reduction in C. jejuni internalization com-
pared to cells infected with C. jejuni in the absence of the inhibitor in
medium alone, as judged by one-way ANOVA followed by post-hoc Tukey’s
analysis (P < 0.05). Each error bar represents ± the standard deviation of the
mean (SD).
Additional file 9: Figure S9. Expression of exogenous caveolin-1 pro-
tein does not alter C. jejuni-invasion of Caco-2 cells. Panels: A) Binding
and internalization of C. jejuni in Caco-2 cells. Cells were transfected with
nothing (None), caveolin-1 (Cav-1) or an empty vector control (Empty). B)
Whole cell lysates of untreated (None), Cav-1 transfected Caco-2 cells,
and Caco-2 cells transfected with an empty vector. Caco-2 lysates were
probed with an α caveolin-1 antibody. The blot was re-probed with an α
tubulin antibody to confirm that equal amounts of protein were loaded
into each well.
Additional file 10: Figure S10. C. jejuni binds to and invades
caveolin-1 positive and negative cells with equal efficiency. C. jejuni
binding and internalization assays were performed with 3T3 mouse
embryonic fibroblasts (MEFs) as outlined in 'Methods.' The 3T3 MEF
wild-type cell line (3T3 MEF WT, CRL-2752) is Cav-1+/+ whereas the
3T3 MEF knockout cell line (3T3 MEF KO, CRL-2753) is Cav-1−/−. The
numbers of C. jejuni bound to and internalized by the 3T3 MEF WT
cells versus the 3T3 MEF KO cells were statistically indistinguishable.
Additional file 11: Figure S11. Hydroxypropyl-β-cyclodextrin (HPβCD)
treatment of HeLa cells disrupts the C. jejuni-dependent association
of phospho-EGF receptor (pEGFR) with β1 integrin. HeLa cells were
infected with C. jejuni in the presence and absence of 20 mM HPβCD
for 45 min. Panels: A) Cell lysates were immunoprecipitated with an
EGFR antibody, separated by SDS-PAGE, and blotted for total EGFR
(loading control), pEGFR, and β1 integrin. HeLa cells were uninfected
(Lanes 1 and 3) or C. jejuni infected (Lanes 2 and 4) in the absence (Lanes 1
and 2) or presence of HPβCD (Lanes 3 and 4). Also shown are the blots of
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and the β1 integrin. B) Quantification of band intensity of pEGFR from three
independent experiments. The asterisk indicates P < 0.01 by one-way
ANOVA followed by post-hoc Dunnet’s analysis.
Additional file 12: Figure S12. Methyl-β-cyclodextrin (MβCD)
treatment of Caco-2 cells (caveolin-1 negative) prevents EGF receptor
(EGFR) activation. Caco-2 cells were infected with C. jejuni with and without
5 mM MβCD treatment or uninfected control (Cells only) for 45 min. Panels:
A) The cell lysates were immunoprecipitated (IP) with an antibody reactive
against the EGFR, separated by SDS-PAGE and blotted for Phospho-EGFR
(pEGFR) and total EGFR. IP with an IgG isotype control antibody yielded no
reactive bands by immunoblot (not shown). Lanes: 1, Uninfected cells (Cells
only); 2, Infected with C. jejuni in the absence of MβCD (vehicle only,
water); 3, Uninfected cells in the presence of 5 mM MβCD; and 4,
Infected with C. jejuni in the presence of 5 mM MβCD. B) Quantification
by densitometry of the pEGFR bands. The mean ± standard deviation of
the pEGFR from three independent blots is indicated in relative optical
density. The asterisk indicates P ≤ 0.05 as judged by one-way ANOVA
followed by post-hoc Dunnet’s analysis.
Abbreviations
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